MARTHA J DEMSKI
CIK 1198230 · last filed 2026-07-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$555.7K
Companies
6
Total Filings
67
Lifetime Open-Market Net
-$821.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TKNO | Director | 12,000 | $5.13 | $61.6K | -$40.5K | 7 | 2026-07-16 |
| EQ | Director | — | $2.31 | — | $0 | 9 | 2026-05-29 |
| CHIMERIX INC (CMRX) Delisted | Director | 0 | $8.54 | $0 | -$781.3K | 32 | 2025-04-21 |
| ADMA | Director | 56,601 | $8.73 | $494.1K | $10.8K | 6 | 2023-03-08 |
| Adamas Pharmaceuticals Inc (ADMS) Delisted | Director | 0 | $8.22 | $0 | -$10.3K | 9 | 2021-11-24 |
| Evofem Biosciences, Inc. (NEOT) Delisted | Director | 2,732 | — | — | $0 | 4 | 2017-06-21 |
Recent Filings · Page 2 of 7
67 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-21 | CHIMERIX INC (CMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | EQ | Grant (A) | — | $0 | EDGAR |
| 2023-09-05 | TKNO | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | CHIMERIX INC (CMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-23 | EQ | Grant (A) | — | $0 | EDGAR |
| 2023-05-11 | CHIMERIX INC (CMRX) Delisted | Buy (P) | +18,000 | $20.0K | EDGAR |
| 2023-03-08 | ADMA | Grant (A) | +25,815 | $0 | EDGAR |
| 2022-06-24 | CHIMERIX INC (CMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-25 | EQ | Grant (A) | — | $0 | EDGAR |
| 2022-05-17 | CHIMERIX INC (CMRX) Delisted | Buy (P) | +10,000 | $16.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.